What is TBPMQ stock price today?

TBPMQ (Tetra Bio-Pharma Inc.) stock is trading at $0.00 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is TBPMQ stock going up or down today?

TBPMQ stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy TBPMQ stock now?

The decision to buy TBPMQ depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is TBPMQ a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for TBPMQ based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is TBPMQ stock overvalued or undervalued?

Use our DCF valuation calculator to determine if TBPMQ is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is TBPMQ's P/E ratio?

P/E ratio data for TBPMQ will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is TBPMQ's market cap?

TBPMQ (Tetra Bio-Pharma Inc.) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is TBPMQ's price to book ratio?

TBPMQ trades at a price-to-book (P/B) ratio of 48.20, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does TBPMQ pay dividends?

TBPMQ does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is TBPMQ's dividend yield?

TBPMQ does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is TBPMQ stock a good long-term investment?

TBPMQ's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is TBPMQ's revenue growth rate?

Revenue growth data for TBPMQ is available on our dashboard with detailed financial statement analysis.

Profitability metrics for TBPMQ are available on our dashboard with complete income statement analysis.

What are the risks of investing in TBPMQ?

Key risks for TBPMQ include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does TBPMQ compare to its competitors?

Compare TBPMQ to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize TBPMQ's performance and positioning.

What is TBPMQ's stock price target for 2026?

Our AI model provides price targets for TBPMQ based on fundamental analysis: Bull case $0.00 (+30%), Base case $0.00 (+15%), Bear case $0.00 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about TBPMQ?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for TBPMQ. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is TBPMQ's next earnings report?

TBPMQ reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

TBPMQ - Tetra Bio-Pharma Inc.

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Tetra Bio-Pharma Inc.

Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of immunomodulator drugs. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; and REBORN for the treatment of breakthrough cancer pain. It also develops novel prescription drugs and treatments to relieve symptoms associated with advanced cancer pain, chronic pain, Acute Respiratory Distress Syndrome, sepsis and ophthalmic disease. The company is headquartered in Orléans, Canada.

TBPMQ Key Statistics

Market Cap

$0.08M

P/B Ratio

48.20

EPS

$-0.06

Employees

How TBPMQ Compares to Peers

TBPMQ is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
TBPMQ(This stock)	$84.67K	N/A	0%	0.0%	-
AMGNAmgen Inc	$187.71B	24.5	0%	0.2%	vs AMGN
GILDGilead Sciences	$173.48B	20.6	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$112.35B	28.8	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$79.71B	18.2	0%	0.3%	vs REGN
BIIBBiogen Inc	$26.50B	20.5	-0%	0.1%	vs BIIB

Tetra Bio-Pharma Inc. Company Information

Headquarters: 2316 St. Boulevard, Orléans, ON, Canada, K1C 1E8, undefined
Website: www.tetrabiopharma.com
Sector: Healthcare
Industry: Biotechnology

Data Updated: April 16, 2026 at 11:41 PM EDT

Ready to invest in TBPMQ?

Commission-free trading available. Affiliate links.

Upcoming Events for TBPMQ

Dashboard

Enter a ticker to analyze